Recombinant Human STX2 Protein，His

STX2 (Syntaxin 2) is a member of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) family, which plays a crucial role in membrane trafficking and fusion processes within cells. Research has shown that STX2 is predominantly expressed in various tissues, including the brain, immune system, and epithelial cells, suggesting its involvement in diverse physiological functions. Alterations in STX2 expression have been linked to several diseases, including neurodegenerative disorders and immune dysregulation, highlighting the importance of understanding its molecular mechanisms. The study of STX2 recombinant proteins offers significant insights into its structural characteristics and functional dynamics, facilitating the identification of potential therapeutic targets. Advances in protein engineering techniques allow researchers to produce STX2 variants, which can be used in functional assays to explore its interactions with other SNARE proteins and regulatory molecules. Elucidating the role of STX2 in cellular pathways could provide vital information for developing treatment strategies for conditions associated with its dysregulation. Furthermore, recombinant STX2 could serve as a valuable tool in drug discovery and biomarker development, enhancing our understanding of vesicular transport mechanisms and their implications in health and disease. Therefore, ongoing research focused on STX2 recombinant proteins is essential for unraveling its biological significance and potential clinical applications.